Form D · Other Health Care
Interlace Medical Inc
Framingham, MA · CIK 0001399684
Offering snapshot reported Jun 17, 2009 · SEC filing
- Reported sold
- $20.5M Offering amount: $20.5M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 10, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 17, 2009 | Initial | $20,500,000 | No comparison | 9 | SEC filing |
| May 1, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-103008
Source: Form D, filed Jun 17, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| J. Daniel Cole | Director |
| Kevin G. Connors | Director |
| William H. Gruber | Director, Executive |
| Milton Mc Coll | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
139 Newbury Street
Framingham, MA, 01701
Phone: 508-875-1343
Framingham, MA, 01701
Phone: 508-875-1343